Antimicrobial prescription pattern and appropriateness for respiratory tract infection in outpatients: a systematic review and meta-analysis
Related Experiment Video
Updated: Jun 14, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Gashaw Enbiyale Kasse1,2, Suzanne M Cosh3, Judy Humphries4
1School of Health, Faculty of Medicine and Health, University of New England, Armidale, 2351, Australia. gkasse@myune.edu.au.
Background:
Millions of people die every year as a result of antimicrobial resistance worldwide. An inappropriate prescription of antimicrobials (e.g., overuse, inadequate use, or a choice that diverges from established guidelines) can lead to a heightened risk of antimicrobial resistance. This study aimed to determine the rate and appropriateness of antimicrobial prescriptions for respiratory tract infections.
Methods:
This review was conducted in accordance with the PRISMA guidelines. Web of Science, PubMed, ProQuest Health and Medicine, and Scopus were searched between October 1, 2023, and December 15, 2023, with no time constraints. Studies were independently screened by the first author and the co-authors. We included original studies reporting antimicrobial prescription patterns and appropriateness for respiratory tract infections. The quality of included studies' was assessed via the Joanna Briggs Institute's Critical Appraisal Checklists for Cross-Sectional Studies. The assessment of publication bias was conducted using a funnel plot and Egger's regression test. A random effect model was employed to estimate the pooled antibiotic prescribing and inappropriate rates. Subgroup analysis was conducted by country, study period, data source, and age group.
Results:
Of the total 1220 identified studies, 36 studies were included in the review. The antimicrobial prescribing rate ranged from 25% (95% CI 0.24-0.26) to 90% (95% CI 0.89-0.91). The pooled antimicrobial prescription rate was 66% (95% CI 0.57 to 0.73). Subgroup analysis by region revealed that the antimicrobial prescription rate was highest in Africa (79%, 95% CI 0.48-0.94) and lowest in Europe (47%, 95% CI 0.32-0.62). Amoxicillin and amoxicillin-clavulanate antimicrobials from the Access group, along with azithromycin and erythromycin from the Watch group, were the most frequently used antimicrobial agents. This study revealed that the major reasons for antimicrobial prescription were acute bronchitis, pharyngitis, sinusitis, and the common cold. The pooled inappropriate antimicrobial prescription rate was 45% (95% CI 0.38-0.52). Twenty-eight of the included studies reported that prescribing antimicrobials without proper indications was the main cause of inappropriate antimicrobial prescriptions. Additionally, subgroup analysis by region showed a higher inappropriate antimicrobial prescription rate in Asia at 49% (95% CI 0.38-0.60). The result of the funnel plot and Egger's tests revealed no substantial publication bias (Egger's test: p = 0.268).
Conclusion:
The prescribing rate and inappropriate use of antimicrobials remain high and vary among countries. Further studies should be conducted to generate information about factors contributing to unnecessary antimicrobial prescriptions in outpatients.
Systematic Review Registration:
Systematic review registration: CRD42023468353.
Insights
Antimicrobial resistance is a global threat. This review found high rates of antimicrobial prescriptions for respiratory infections, with 45% being inappropriate, highlighting a critical need for improved prescribing practices.
Area of Science:
- Infectious Diseases
- Public Health
- Pharmacology
Background:
- Antimicrobial resistance (AMR) causes millions of deaths globally.
- Inappropriate antimicrobial prescribing, including overuse and deviation from guidelines, escalates AMR risk.
- Respiratory tract infections are frequently treated with antimicrobials, necessitating an evaluation of prescription patterns.
Purpose of the Study:
- To determine the rate of antimicrobial prescriptions for respiratory tract infections.
- To assess the appropriateness of these antimicrobial prescriptions.
- To identify patterns and potential drivers of antimicrobial misuse.
Main Methods:
- A systematic review adhering to PRISMA guidelines was conducted.
- Searches were performed across major databases (Web of Science, PubMed, ProQuest, Scopus).
- Data from 36 original studies were analyzed using random-effect models, with subgroup analyses by region and age.
Main Results:
- The pooled antimicrobial prescription rate for respiratory infections was 66%, with significant regional variation (highest in Africa at 79%, lowest in Europe at 47%).
- The pooled inappropriate antimicrobial prescription rate was 45%, with Asia showing a higher rate (49%).
- Commonly prescribed antimicrobials included amoxicillin, amoxicillin-clavulanate, azithromycin, and erythromycin, often for acute bronchitis, pharyngitis, sinusitis, and the common cold.
Conclusions:
- High rates of antimicrobial prescribing and inappropriate use persist globally for respiratory tract infections.
- Significant variations in prescribing rates and appropriateness exist across different countries and regions.
- Further research is needed to understand and address the factors contributing to unnecessary antimicrobial prescriptions in outpatient settings.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Pneumonia III: Complications and Assessment